Growing Adoption Opentrons' robotics platform is widely adopted across more than 40 countries, including academic, biopharma, and research institutions, indicating a strong market presence and increasing potential for expansion in global life science labs.

Strategic Partnerships Recent collaborations with industry leaders like MilliporeSigma and Nicoyalife highlight opportunities to co-develop customized automation solutions, serving as an entry point for selling tailored automation hardware and protocol services.

Educational Expansion The launch of Opentrons for Education opens avenues for sales in academic settings, with potential for selling lab kits, curriculum integration services, and automation tools to educational institutions focusing on STEM.

Innovative Offerings The introduction of products like Flex Prep and comprehensive protocol libraries positions Opentrons as a provider of easy-to-use, no-code automation solutions, ideal for labs seeking flexible and accessible robotic systems—great opportunities for upselling and new customer acquisition.

Financial Strength With over 202 million USD in funding and revenue between 50 to 100 million USD, Opentrons is in a strong financial position to invest in targeted outreach, marketing campaigns, and channel partnerships to accelerate sales growth within the biotech and research markets.